阿奇霉素杂质09对照品

红霉素肟A;(9E)-红霉素A肟;红霉素肟;红霉素肟Erythromycin, 9-oxime,(9E)- (9CI);红霉素杂质J;依美溴铵;(E)-红霉素肟;罗红霉素EP杂质C;(9E)-红霉素A肟罗红霉素杂质C;阿奇霉素杂质S ((9E)-ERYTHROMYCIN A OXIME)

(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2R,3R,4S,6R)- 4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2- yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5- hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl) oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyl oxacyclotetradecan-2-one

Erythromycin, 9-oxime,(9E)- (9CI);Erythromycin A Oxime;(9E)-Erythromycin A Oxime;(E)-Erythromycin oxime;ERYTHROMYCIN OXIME BASE;(E)-Erythromycin A oxime;Oxacyclotetradecane,erythromycin deriv.;Erythromycin Impurity J;Azithromycin Impurity S ((9E)-Erythromycin A Oxime);Roxithromycin EP Impurity C (Erythromycin Impurity J);(9E)-Erythromycin A Oxime Roxithromycin EP Impurity C;(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-10-(hydroxyimino)-3,5,7,9

111321-02-9

C₃₇H₆₈N₂O₁₃

仅用于研发试验中鉴别、检查。111321-02-9|阿奇霉素杂质09对照品,≥97%，制备中，详情请联系Medlife客服进行咨询。(3R,4S,5S,6R,7R,9R,11S,12R,13S,14R,E)-6-(((2R,3R,4S,6R)- 4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2- yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5- hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl) oxy)-10-(hydroxyimino)-3,5,7,9,11,13-hexamethyl oxacyclotetradecan-2-one可放大生产，批量保障。